News

A team of researchers at the University of Kentucky is working to better understand the impact of opioid use disorder on mothers and babies.

Collaborative research by former UK College of Pharmacy Professor Hsin-Hsiung Tai, Ph.D., Case Western Reserve University and University of Texas Southwestern has been acquired by Amgen Inc.

The Chan Zuckerberg Initiative (CZI) has funded a University of Kentucky open source software project aimed at advancing scientific and biomedical research. Derek Young will use the grant to significantly modernize and enhance his two R packages, titled “mixtools” and “tolerance.”

Dr. Emma Birks, UK HealthCare's heart failure section chief, is working on a new treatment therapy that recovers the hearts of some patients with advanced-stage chronic heart failure and ultimately cut down the number of heart transplants needed.

The challenge, Moseley says, is in analyzing this complex data to derive new biological knowledge and in making this data and knowledge available in a highly reusable format in public scientific repositories.

"Our outstanding researchers at the University of Kentucky are leading the way in translational chemical biology, and the recently awarded COBRE grant is a testament to UK CPRI’s success in their constant pursuit of discovery," said UK President Eli Capilouto.

Guoqiang Yu has been awarded two grants from the National Institutes of Health that total nearly $4.7 million. Yu researches near-infrared diffuse optical spectroscopy/tomography through his Biomedical Optics Lab.

Next week, UK College of Medicine and the Department of Chemistry in the UK College of Arts and Sciences will host renowned biochemist Dr. Rafael Radi for two special events on campus.

A study in the January issue of Clinical Biomechanics helps shed light on the short-term outcome of arthroscopic surgery for a painful hip condition known as femoroacetabular impingement syndrome (FAIS).

In October 2018, it was announced that UK and regional partners had received a federal NIH grant that could potentially total $3.5 million over three years to create a hub to accelerate the commercialization of biomedical technologies.